Announcements Trials
Browse Landscape

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 7Observational 2

Sponsor

Cancer Type

Thoracic 1Breast 1

Conditions

Triple Negative Breast Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Blood Specimen Collection 137Surveys and Questionnaires 131Specimen Handling 57Observation 55Radiotherapy 44Interviews as Topic 35Drug Therapy 31Surgical Procedures, Operative 31Biopsy 30Data Collection 25Magnetic Resonance Spectroscopy 25Nivolumab 21Watchful Waiting 20Immune Checkpoint Inhibitors 19Magnetic Resonance Imaging 17Standard of Care 17Therapeutics 17Immunotherapy 16palbociclib 14trastuzumab deruxtecan 14Liquid Biopsy 13Restraint, Physical 13Tomography, X-Ray Computed 13Hematologic Tests 12Radiosurgery 12Focus Groups 11Genetic Testing 11darolutamide 11enzalutamide 11pembrolizumab 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Combined Modality Therapy × 1 year × Clear all
NCT07610616 2026-05-28

Study on the Mechanism of ADC Drug Evaluation Based on Immune Co-culture of Lung Cancer Organoids

Guangzhou Institute of Respiratory Disease

Recruiting
10 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07018427 2025-06-12

Real-world Study of Sacituzumab Govitecan Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer

Peking University Cancer Hospital & Institute

Active not recruiting
70 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡